An assesment of Singapore's biomedical sciences landscape with reference to Japan and Taiwan

• Main Authors: Lim, Yvonne Kha Hui, Pang, Cheng Biing
• Other Authors: Seet, Lip Chai
• Format: Theses and Dissertations
• Published: 2008
• Subjects: DRNTU::Business::Industries and labor
• Online Access: http://hdl.handle.net/10356/7476
• Institution: Nanyang Technological University

The revolutionary science of 'Biotechnology' is emerging as a 'technology of hope' for humankind. By integrating life sciences, biochemistry, molecular biology, chemical engineering and computer sciences, biotechnology can have profound impact in the fields of medicine, agriculture, animal farming and environmental protection. Low cost medicine, breakthrough discoveries to manage illnesses and diseases, improved livestock and crops are now within grasp of making this a reality. Recognising this revolutionary potential of biotechnology, the government has designated Biomedical Sciences (BMS) to be the fourth economic pillar of Singapore. The vision is to develop Singapore into a global hub for biomedical sciences in Asia. This research will assess Singapore's competitive advantage against 2 regional neighbours, Japan and Taiwan, using a set of identified key success factors based on OTA (1984) framework, United Nations (2004) study paper, European Commission (2002) study paper and the Diamond model (Porter, 1990). Interviews with industry players were also done to include a current industry perspective.